No Additional Doses of Gardasil 9 Are Needed
A 16-year-old who completed a two-dose Gardasil 4 series at age 12 does not require any doses of Gardasil 9 and is considered fully vaccinated.
Rationale
Since this patient initiated HPV vaccination before age 15 (at age 12) and completed a two-dose series, they meet the current definition of adequate vaccination. The two-dose schedule is considered complete and protective when started before the 15th birthday 1.
Key Considerations:
Age at Initiation Determines Dosing Schedule:
- Vaccination initiated before age 15: 2-dose series is complete (0,6-12 months) 1
- Vaccination initiated at age 15 or later: 3-dose series required 1
Cross-Protection from Gardasil 4:
- Gardasil 4 provides protection against HPV types 6,11,16, and 18
- These four types account for approximately 70% of cervical cancers and 90% of genital warts 1
- The patient already has robust immunity to these critical oncogenic types
Gardasil 9 Supplementation Data:
- While Gardasil 9 adds coverage for five additional high-risk types (31,33,45,52,58), the FDA label data shows that individuals previously vaccinated with Gardasil 4 who later received Gardasil 9 achieved lower antibody titers (25-63% of GMTs) compared to vaccine-naïve individuals 2
- The clinical significance of supplemental Gardasil 9 vaccination in previously vaccinated individuals remains unknown 2, 3
- No efficacy data exists for Gardasil 9 in preventing disease from the five additional types in those already vaccinated with Gardasil 4 2
Important Caveats
This recommendation assumes:
- The two doses were appropriately spaced (minimum 5 months apart, ideally 6-12 months)
- The patient was immunocompetent at the time of vaccination
- Both doses were documented and verified
If considering supplemental Gardasil 9 (not routinely recommended):
- This would be an off-label use without established benefit
- Would require shared decision-making about uncertain additional protection
- The patient would need a full 3-dose series of Gardasil 9 if pursued 2, 3
Continue routine cervical cancer screening per guidelines regardless of vaccination status, as vaccines do not protect against all oncogenic HPV types 4, 5.